• LAST PRICE
    16.7700
  • TODAY'S CHANGE (%)
    Trending Up0.2700 (1.6364%)
  • Bid / Lots
    16.0200/ 1
  • Ask / Lots
    18.8600/ 1
  • Open / Previous Close
    16.3700 / 16.5000
  • Day Range
    Low 15.5650
    High 16.8400
  • 52 Week Range
    Low 7.0900
    High 31.4300
  • Volume
    105,669
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 16.5
TimeVolumeNUVL
09:32 ET35216.37
09:43 ET10016.84
09:56 ET30016.01
09:57 ET30016.4
10:03 ET10015.98
10:06 ET10015.98
10:08 ET242815.78
10:14 ET10015.565
10:21 ET54315.975
10:24 ET40015.95
10:26 ET10016.08
10:33 ET44616.09
10:35 ET20016.04
10:48 ET20016.13
10:50 ET10016.24
10:51 ET23016.155
11:06 ET10016.11
11:09 ET10016.23
11:13 ET40016.235
11:20 ET329416.3996
11:36 ET10016.41
11:44 ET10016.38
11:47 ET10016.36
11:51 ET10016.37
11:54 ET30016.37
11:56 ET10016.45
12:00 ET10016.45
12:02 ET10016.46
12:03 ET10016.46
12:07 ET30016.36
12:09 ET10016.3
12:14 ET50016.315
12:16 ET10016.35
12:18 ET80016.32
12:20 ET10016.3
12:21 ET20016.31
12:27 ET19816.3
12:30 ET10016.3
12:43 ET50016.39
12:48 ET10016.47
12:52 ET10016.45
12:57 ET10016.47
01:01 ET30016.415
01:06 ET50016.5
01:12 ET10016.48
01:14 ET20016.36
01:15 ET10016.45
01:19 ET10016.5
01:26 ET10016.5
01:30 ET10016.36
01:37 ET163416.3
01:46 ET10016.24
01:48 ET10016.38
01:51 ET83116.26
01:57 ET10016.4
02:00 ET10016.4
02:02 ET10016.33
02:11 ET110016.245
02:13 ET60016.29
02:18 ET50016.27
02:33 ET190016.33
02:40 ET100016.295
02:49 ET10016.29
02:51 ET143316.31
02:54 ET120016.3
02:56 ET70016.3
02:58 ET300016.29
03:00 ET260016.27
03:02 ET280016.3
03:07 ET276316.41
03:09 ET10016.42
03:14 ET50116.38
03:16 ET20016.39
03:18 ET10016.4
03:20 ET40016.41
03:21 ET50016.42
03:30 ET40016.45
03:32 ET60016.48
03:34 ET40016.55
03:36 ET30016.7
03:38 ET20016.55
03:41 ET20016.6
03:43 ET30016.69
03:45 ET40016.6
03:48 ET80016.6
03:50 ET80016.52
03:52 ET59016.52
03:54 ET40016.54
03:56 ET70016.55
03:57 ET791616.66
03:59 ET1650216.77
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNUVL
Nuvalent Inc
811.9M
-11.3x
---
United StatesRCKT
Rocket Pharmaceuticals Inc
817.0M
-4.2x
---
United StatesIGMS
IGM Biosciences Inc
819.0M
-3.4x
---
United StatesVRDN
Viridian Therapeutics Inc
823.8M
-4.5x
---
United StatesDSGN
Design Therapeutics Inc
786.3M
-15.4x
---
United StatesKURA
Kura Oncology Inc
838.8M
-6.3x
---
As of 2022-09-25

Company Information

Nuvalent, Inc. is a preclinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. The Company is advancing a pipeline of product candidates with parallel programs in cancers driven by genomic alterations in the ROS proto-oncogene 1 (ROS1) and anaplastic lymphoma kinase (ALK), along with multiple discovery-stage research programs. Its lead product candidate, NVL-520, is a ROS1-selective inhibitor designed to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases. The Company’s product candidate also includes NVL-655, which is a brain-penetrant ALK-selective inhibitor that is designed to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that may limit the use of first, second and third-generation ALK inhibitors.

Contact Information

Headquarters
One Broadway, 14th FloorCAMBRIDGE, MA, United States 02142
Phone
857-357-7000
Fax
302-655-5049

Executives

Independent Chairman of the Board
Anna Protopapas
President, Chief Executive Officer, Director
James Porter
Chief Financial Officer, Treasurer
Alexandra Balcom
Senior Vice President - Product Development and Regulatory Affairs
Darlene Noci
Chief Medical Officer
Christopher Turner

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$811.9M
Revenue (TTM)
$0.00
Shares Outstanding
48.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.49
Book Value
$5.90
P/E Ratio
-11.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.